EXHIBIT 10.1
ADVAXIS, INC.

NOTE PURCHASE AGREEMENT

THIS NOTE PURCHASE AGREEMENT (this “Agreement”) is made as of the 22 day of
September, 2008, by and between Advaxis, Inc., a Delaware corporation (the
“Company”), and Thomas A. Moore, an individual (the “Investor”).

Recitals
 
The Investor is the Chief Executive Officer and a member of the Board of
Directors of the Company.
 
The Company desires to issue and sell, and the Investor desires to purchase,
upon the Company’s demand upon 10 business days’ notice, one or more senior
promissory notes with an aggregate principal amount of up to eight hundred
thousand dollars ($800,000.00) in substantially the form attached to this
Agreement as Exhibit 4.1 (each, a “Note”).

The Company and the Investor desire that, upon the consummation of a future
equity financing by the Company, the Company issue to the Investor warrants to
purchase the Company’s common stock as described herein.

The Company and the Investor desire to set forth certain agreements and certain
terms and conditions regarding the sale and purchase of the Notes.

Agreement

NOW, THEREFORE, in consideration of the foregoing premises, the respective
representations, warranties and covenants contained herein, and certain other
good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties agree as follows:

1. PURCHASE AND SALE OF THE NOTES.

1.1 Purchase and Sale of the Notes. Subject to the terms and conditions of this
Agreement and in reliance on the representations and warranties set forth in
this Agreement, following the delivery by the Company to the Investor of a
written notice (each, a “Demand Notice”) in accordance with Section 6.7, the
Company agrees to issue, sell and deliver to the Investor at the Closing (as
defined below), and the Investor agrees to purchase from the Company at the
Closing, a Note in the principal amount set forth in the Demand Notice. The
Company shall be entitled to deliver one or more Demand Notices to the Investor
for an aggregate principal amount of no more than eight hundred thousand dollars
($800,000.00).

1.2 Closing. The closing and funding of the purchase and sale of each Note
(each, a “Closing”) shall take place at the offices of Greenberg Traurig, LLP,
200 Park Avenue, New York, New York 10166 no more than ten (10) business days
following the date of each Demand Notice as determined in accordance with
Section 6.7, or at such other time and place as the Company and the Investor
mutually agree upon in writing.
 

--------------------------------------------------------------------------------

 
2. WARRANTS. 

In consideration of the Investor’s agreement to purchase Notes, the Company
agrees that, concurrently with the consummation of the Company’s next equity
financing resulting in gross proceeds to the Company of at least $5,000,000, the
Company shall issue to the Investor a warrant to purchase the Company’s common
stock (the “Warrant”). The Warrant shall entitle the Investor to purchase a
number of shares of the Company’s common stock equal to one share per $1.00
invested by the Investor in the purchase of one or more Notes, which share
amount shall be subject to appropriate adjustment for stock splits, stock
dividends and similar events. The Warrant shall otherwise be on the same terms,
including but not limited to exercise price, mechanics of execution and
registration rights, applicable to warrants issued to the new investors in such
equity financing. In the event that such equity financing does not involve the
issuance of warrants, then the Warrant shall have an exercise price equal to the
effective purchase price per share paid by investors in such equity financing,
and the Investor shall receive registration rights with respect to shares of the
Company’s common stock underlying the Warrant on the same terms as securities
purchased by such investors.

3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

As of each Closing, the Company hereby represents and warrants to the Investor
as follows:

3.1 Organization and Standing. The Company is a corporation duly organized and
validly existing under, and by virtue of, the laws of the State of Delaware and
is in good standing under such laws. The Company has requisite corporate power
and authority to own and operate its properties and assets, and to carry on its
business as presently conducted. The Company is duly qualified to do business in
each jurisdiction in which the failure to be so qualified would have a material
adverse effect on the Company’s business.

3.2 Corporate Power. The Company has all requisite legal and corporate power and
authority to execute and deliver this Agreement and each Note to be dated the
date of each Closing (collectively, the “Transaction Agreements”) and to carry
out and perform its obligations under the terms of each of the Transaction
Agreements.

3.3 Authorization. All corporate action on the part of the Company, its officers
and directors necessary for the authorization, execution, delivery and
performance of the Transaction Agreements and the performance of all obligations
of the Company hereunder and thereunder has been taken or will be taken prior to
each Closing. Each Transaction Agreement, when executed and delivered by the
Company, shall constitute a valid and binding obligation of the Company,
enforceable in accordance with its respective terms, except as limited by
applicable bankruptcy, insolvency, reorganization, moratorium and other laws of
general application affecting enforcement of creditors’ rights generally and as
limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies.
 

--------------------------------------------------------------------------------

 
3.4 Offering. Subject to truth and accuracy of the Investor’s representations in
Section 4 hereof, the offer, sale and issuance of the Notes constitute
transactions exempt from the registration requirements of Section 5 of the
Securities Act of 1933, as amended (the “Securities Act”), and in compliance
with applicable state securities laws.

4. REPRESENTATIONS AND WARRANTIES OF THE INVESTOR. The Investor represents and
warrants to the Company as of the time of each Closing as follows:

4.1 Authorization. This Agreement, when executed and delivered by the Investor
shall constitute a valid and binding obligation of the Investor, enforceable in
accordance with its terms, except as limited by applicable bankruptcy,
insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors’ rights generally and as limited by laws
relating to the availability of specific performance, injunctive relief or other
equitable remedies.

4.2 Purchase Entirely for Own Account. This Agreement is made with the Investor
in reliance upon the Investor’s representation to the Company, which by the
Investor’s execution of this Agreement the Investor hereby confirms, that each
Note will be acquired for investment for the Investor’s own account, not as a
nominee or agent, and not with a view to the resale or distribution of any part
thereof, and that the Investor has no present intention of selling, granting any
participation in, or otherwise distributing the same. By executing this
Agreement, the Investor further represents that the Investor does not have any
contract, undertaking, agreement or arrangement with any person to sell,
transfer or grant participations to such person or to any third person with
respect to any Note.

4.3 Disclosure of Information. The Investor believes he has received all the
information he considers necessary or appropriate for deciding whether to
purchase Notes. The Investor further represents that he has had an opportunity
to ask questions and receive answers from the Company regarding the terms and
conditions of the offering of the Notes and the business, properties, prospects
and financial condition of the Company.

4.4 Accredited Investor. The Investor is an “accredited investor” within the
meaning of Rule 501 of Regulation D of the Securities Act.

4.5 Restricted Securities. The Investor acknowledges that the Notes may have to
be held indefinitely, and may not be sold or transferred, unless subsequently
registered under the Securities Act or unless an exemption from such
registration is available. The Investor is aware of the provisions of Rule 144
promulgated under the Securities Act which permits limited resale of securities
purchased in a private placement subject to the satisfaction of certain
conditions.

5. LEGENDS. The certificates representing each Note shall be endorsed with a
legend substantially as follows:
 
THIS SENIOR PROMISSORY NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAW. NO SALE,
TRANSFER, PLEDGE OR ASSIGNMENT OF THIS SENIOR PROMISSORY NOTE SHALL BE VALID OR
EFFECTIVE UNLESS (A) SUCH TRANSFER IS MADE PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT AND IN COMPLIANCE WITH ANY APPLICABLE STATE
SECURITIES LAW, OR (B) SUCH TRANSFER IS MADE PURSUANT TO AN EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND OF ANY APPLICABLE STATE
SECURITIES LAW.
 
 
 

--------------------------------------------------------------------------------

 
 
6. MISCELLANEOUS.

6.1 Waivers and Amendments. With the written consent of the Company and the
Investor, the obligations of the Company and the rights of the Investor under
this Agreement may be waived (either generally or in a particular instance,
either retroactively or prospectively and either for a specified period of time
or indefinitely) or this Agreement may be amended. Neither this Agreement nor
any provisions hereof may be changed, waived, discharged or terminated orally,
but only by a signed statement in writing.

6.2 Governing Law. This agreement shall be governed in all respects by the laws
of the State of Delaware, without regard to conflict of laws rules.

6.3 Survival. The representations, warranties, covenants and agreements made
herein shall survive each Closing.

6.4 Titles and Subtitles. The titles of the sections of this Agreement are for
convenience of reference only and are not to be considered in construing this
Agreement.

6.5 Assignment. This Agreement shall be binding upon the Company, the Investor
and their respective heirs, executors, administrators, assigns and legal
representatives.

6.6 Entire Agreement. This Agreement contains the entire understanding of the
parties hereto with respect to the subject matter hereof, and supersedes all
other agreements between or among any of the parties with respect to the subject
matter hereof.

6.7 Notices. All notices and other communications required or permitted
hereunder shall be in writing and may be delivered in person or by facsimile,
electronic mail, courier or U.S. mail, in which event it may be mailed by
first-class, certified or registered, postage prepaid, addressed (a) if to the
Investor, at the address set forth on the signature page of this Agreement, or
at such other address as the Investor shall, from time to time, designate to the
Company in writing or (b) if to the Company, at such address set forth on the
signature page of this Agreement, or at such other address as the Company shall
have furnished to the Investor in writing. All such notices and other
communications shall be deemed given upon personal delivery, upon confirmation
of facsimile transfer, upon confirmation of electronic mail transmission, upon
delivery by courier or three business days after deposit in the United States
mail. Notwithstanding the foregoing, all notices and communications to addresses
outside the United States shall be given by facsimile and confirmed in writing
sent by overnight or two-day courier service.

6.8 Severability. In the event one or more of the provisions of this Agreement
should, for any reason, be held to be invalid, illegal or unenforceable in any
respect, such invalidity, illegality or unenforceability shall not affect any
other provisions of this Agreement and this Agreement shall be construed as if
such invalid, illegal or unenforceable provision had never been contained
herein.
 

--------------------------------------------------------------------------------

 
6.9 Expenses. The Company and the Investor shall each bear their own expenses
incurred with respect to this transaction.

6.10 Counterparts. This Agreement may be executed in two or more counterparts,
each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument.

6.11 Telecopy Execution and Delivery. A facsimile, telecopy or other
reproduction of this Agreement may be executed by one or more parties hereto,
and an executed copy of this Agreement may be delivered by one or more parties
hereto by facsimile or similar electronic transmission device pursuant to which
the signature of or on behalf of such party can be seen, and such execution and
delivery shall be considered valid, binding and effective for all purposes. At
the request of any party hereto, all parties hereto agree to execute an original
of this Agreement as well as any facsimile, telecopy or other reproduction
hereof.

[Signature Page Follows]
 

--------------------------------------------------------------------------------

IN WITNESS WHEREOF, the parties have executed this Agreement on the day, month
and year first set forth above.

 
COMPANY:
     
ADVAXIS, INC.
     
By:
           
   
Name: Fred Cobb
   
Title: Vice President Finance
     
Address:
   
Technology Centre of New Jersey
   
675 Rt. 1, Suite B113
   
North Brunswick, N.J. 08902
         
Fax: 732-545-1084
   
e-mail:cobb@Advaxis.com
     
INVESTOR:
         
              
 
Thomas A. Moore
         
Address:
       
Technology Centre of New Jersey
675 Rt. 1, Suite B113
   
North Brunswick, N.J. 08902
         
Fax: 732-545-1084
   
e-mail: moore@advaxis.com

 

--------------------------------------------------------------------------------